Role of Risk Factors in the Modulation of Tissue Factor Activity and Blood Thrombogenicity-Reference-Cited by-同舟云学术

Role of Risk Factors in the Modulation of Tissue Factor Activity and Blood Thrombogenicity

Published:2003-02-25 Issue:7 Volume:107 Page:973-977
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Sambola Antonia¹,Osende Julio¹,Hathcock James¹,Degen Michael¹,Nemerson Yale¹,Fuster Valentin¹,Crandall Jill¹,Badimon Juan Jose¹

Affiliation:

1. From the Cardiovascular Biology Research Laboratory (A.S., J.O., J.J.B.), Zena and Michael A. Wiener Cardiovascular Institute (A.S., J.O., V.F.), Division of Thrombosis (J.H., M.D., Y.N.), and Division of Endocrinology (J.C.), Mount Sinai School of Medicine, New York, NY.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Tissue Factor: Then and Now

2. Circulating tissue factor and thrombosis

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smoking paradox in coronary function and structure of acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention;BMC Cardiovascular Disorders;2024-08-14

2. The enigma of the ‘smoker's paradox’: Results from a single-center registry of patients with STEMI undergoing primary percutaneous coronary intervention;Cardiovascular Revascularization Medicine;2024-06

3. Effect of smoking status on clinical outcomes after reperfusion therapy for acute ischemic stroke;Scientific Reports;2024-04-23

4. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus;Cardiovascular Diabetology;2024-02-20

5. Molecular Mechanisms Linking Diabetes with Increased Risk of Thrombosis;International Journal of Molecular Sciences;2023-12-14